Triple agonists will potentially be appropriate for patients with severe obesity requiring maximum intervention, those who havent responded adequately to dual agonists, patients willing to participate in clinical trials under strict medical supervision, and individuals who have plateaued on current therapies
Based on what we know so far, it will likely carry similar risks and side effects to medications like semaglutide and tirzepatide
In addition, labile iron pools can catalyze lipid radical propagation through Fenton-type reactions, further amplifying membrane lipid peroxidation [71, 72]
And the review doesnt show that berberine can be applied on a patch and absorbed through the bloodstream, Jay adds
While GLP-1 medications don't come with a universal playbook for stopping them, experts generally discourage quitting without a plan